Literature DB >> 21446973

Chronic progressive calcineurin nephrotoxicity: an overstated concept.

Arthur J Matas1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21446973      PMCID： PMC3342642          DOI： 10.1111/j.1600-6143.2011.03505.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN： 1600-6135            Impact factor:   8.086


× No keyword cloud information.
  42 in total

1.  Immunologic factors: the major risk for decreased long-term renal allograft survival.

Authors:  A Humar; A Hassoun; R Kandaswamy; W D Payne; D E Sutherland; A J Matas
Journal:  Transplantation       Date:  1999-12-27       Impact factor: 4.939

2.  Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies?

Authors:  Herwig-Ulf Meier-Kriesche; Jesse D Schold; Bruce Kaplan
Journal:  Am J Transplant       Date:  2004-08       Impact factor: 8.086

3.  Capillary deposition of C4d complement fragment and early renal graft loss.

Authors:  H E Feucht; H Schneeberger; G Hillebrand; K Burkhardt; M Weiss; G Riethmüller; W Land; E Albert
Journal:  Kidney Int       Date:  1993-06       Impact factor: 10.612

4.  An integrated view of molecular changes, histopathology and outcomes in kidney transplants.

Authors:  P F Halloran; D G de Freitas; G Einecke; K S Famulski; L G Hidalgo; M MengeL; J Reeve; J Sellares; B Sis
Journal:  Am J Transplant       Date:  2010-10       Impact factor: 8.086

5.  Cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; J Ross; L Newton; J Luetscher; M Perlroth
Journal:  N Engl J Med       Date:  1984-09-13       Impact factor: 91.245

6.  The natural history of chronic allograft nephropathy.

Authors:  Brian J Nankivell; Richard J Borrows; Caroline L-S Fung; Philip J O'Connell; Richard D M Allen; Jeremy R Chapman
Journal:  N Engl J Med       Date:  2003-12-11       Impact factor: 91.245

7.  Risk factors for chronic rejection in renal allograft recipients.

Authors:  P S Almond; A Matas; K Gillingham; D L Dunn; W D Payne; P Gores; R Gruessner; J S Najarian
Journal:  Transplantation       Date:  1993-04       Impact factor: 4.939

8.  The long-term course of cyclosporine-associated chronic nephropathy.

Authors:  B D Myers; R Sibley; L Newton; S J Tomlanovich; C Boshkos; E Stinson; J A Luetscher; D J Whitney; D Krasny; N S Coplon
Journal:  Kidney Int       Date:  1988-02       Impact factor: 10.612

9.  Renal glomerular lesions in unselected patients with cirrhosis undergoing orthotopic liver transplantation.

Authors:  R A Axelsen; D H Crawford; Z H Endre; S V Lynch; G A Balderson; R W Strong; S J Fleming
Journal:  Pathology       Date:  1995-07       Impact factor: 5.306

10.  Chronic renal failure after transplantation of a nonrenal organ.

Authors:  Akinlolu O Ojo; Philip J Held; Friedrich K Port; Robert A Wolfe; Alan B Leichtman; Eric W Young; Julie Arndorfer; Laura Christensen; Robert M Merion
Journal:  N Engl J Med       Date:  2003-09-04       Impact factor: 91.245
View more
  16 in total

Review 1.  The impact of donor-specific anti-HLA antibodies on late kidney allograft failure.

Authors:  Alexandre Loupy; Gary S Hill; Stanley C Jordan
Journal:  Nat Rev Nephrol       Date:  2012-04-17       Impact factor: 28.314

2.  Moving Beyond Minimization Trials in Kidney Transplantation.

Authors:  Arthur J Matas; Robert S Gaston
Journal:  J Am Soc Nephrol       Date:  2015-04-29       Impact factor: 10.121

3.  Non-immunologic allograft loss in pediatric kidney transplant recipients.

Authors:  Isa F Ashoor; Vikas R Dharnidharka
Journal:  Pediatr Nephrol       Date:  2018-02-26       Impact factor: 3.714

4.  Minimization vs tailoring: Where do we stand with personalized immunosuppression during renal transplantation in 2015?

Authors:  Lajos Zsom; László Wagner; Tibor Fülöp
Journal:  World J Transplant       Date:  2015-09-24

5.  Calcineurin inhibitors: short-term friend, long-term foe?

Authors:  A J Matas
Journal:  Clin Pharmacol Ther       Date:  2011-08       Impact factor: 6.875

6.  Tacrolimus trough levels after month 3 as a predictor of acute rejection following kidney transplantation: a lesson learned from DeKAF Genomics.

Authors:  Ajay K Israni; Samy M Riad; Robert Leduc; William S Oetting; Weihua Guan; David Schladt; Arthur J Matas; Pamala A Jacobson
Journal:  Transpl Int       Date:  2013-07-24       Impact factor: 3.782

7.  Late kidney dysfunction in a kidney transplant recipient.

Authors:  Michelle A Josephson
Journal:  Clin J Am Soc Nephrol       Date:  2013-12-26       Impact factor: 8.237

Review 8.  The role of pharmacogenetics in the disposition of and response to tacrolimus in solid organ transplantation.

Authors:  Dennis A Hesselink; Rachida Bouamar; Laure Elens; Ron H N van Schaik; Teun van Gelder
Journal:  Clin Pharmacokinet       Date:  2014-02       Impact factor: 6.447

Review 9.  Challenges and considerations in diagnosing the kidney disease in deteriorating graft function.

Authors:  Henrik Ekberg; Martin E Johansson
Journal:  Transpl Int       Date:  2012-06-28       Impact factor: 3.782

10.  Campath, calcineurin inhibitor reduction and chronic allograft nephropathy (3C) study: background, rationale, and study protocol.

Authors:  Richard Haynes; Colin Baigent; Paul Harden; Martin Landray; Murat Akyol; Argiris Asderakis; Alex Baxter; Sunil Bhandari; Paramit Chowdhury; Marc Clancy; Jonathan Emberson; Paul Gibbs; Abdul Hammad; Will Herrington; Kathy Jayne; Gareth Jones; Nithya Krishnan; Michael Lay; David Lewis; Iain Macdougall; Chidambaram Nathan; James Neuberger; Chas Newstead; Ravi Pararajasingam; Carmelo Puliatti; Keith Rigg; Peter Rowe; Adnan Sharif; Neil Sheerin; Sanjay Sinha; Chris Watson; Peter Friend
Journal:  Transplant Res       Date:  2013-05-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.